By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Conatus Pharmaceuticals Inc. 

4365 Executive Drive
Suite 200
San Diego  California  92121  U.S.A.
Phone: 858-457-7221 Fax: 858-558-8920


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Conatus Pharma Announces Completion Of Enrollment In ENCORE-NF Phase IIb Clinical Trial Of Emricasan In Patients With NASH Fibrosis 8/15/2017 8:25:33 AM
Conatus Pharma Appoints Keith W. Marshall As Executive Vice President, Chief Operating Officer And Chief Financial Officer 8/4/2017 8:07:44 AM
Conatus Pharma Reports Second Quarter 2017 Financial Results And Program Updates 8/3/2017 1:42:23 PM
Conatus Pharma To Report Second Quarter 2017 Financial Results 7/27/2017 1:05:30 PM
Conatus Pharma Announces Effectiveness Of Exclusive License For Global Development And Commercialization Of Emricasan With Receipt Of $7 Million Payment 7/7/2017 10:36:58 AM
FDA Grants Conatus Pharma Orphan Drug Designation For IDN-7314 For The Treatment Of PSC 6/26/2017 12:18:49 PM
Conatus Pharma Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/17/2017 11:18:08 AM
Conatus Pharma Announces Proposed Public Offering Of Common Stock 5/11/2017 12:58:22 PM
Conatus Pharma Announces Pricing Of Public Offering Of Common Stock 5/11/2017 8:45:57 AM
Novartis AG (NVS) Dives Deeper Into NASH With Exclusive Deal With Conatus Pharma 5/4/2017 6:41:25 AM
12345678910...
//-->